TABLE OF CONTENTS
Volume 25, Issue 49 (19 October 2006)
Original Articles
Effect of aspirin on the Wnt/
-catenin pathway is mediated via protein phosphatase 2A
C L Bos, L L Kodach, G R van den Brink, S H Diks, M M van Santen, D J Richel, M P Peppelenbosch and J C H Hardwick
Oncogene 25: 6447-6456; advance online publication, July 31, 2006; doi:10.1038/sj.onc.1209658
Unique role of SNT-2/FRS2
/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways
L Huang, M Watanabe, M Chikamori, Y Kido, T Yamamoto, M Shibuya, N Gotoh and N Tsuchida
Oncogene 25: 6457-6466; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209656
Tuberin activates the proapoptotic molecule BAD
A Freilinger, M Rosner, G Krupitza, M Nishino, G Lubec, S J Korsmeyer and M Hengstschläger
Oncogene 25: 6467-6479; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209660
MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2
C-L Huang, M Ueno, D Liu, D Masuya, J Nakano, H Yokomise, T Nakagawa and M Miyake
Oncogene 25: 6480-6488; advance online publication, May 8, 2006; doi:10.1038/sj.onc.1209654
Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3 -/- mice
W Cruz-Munoz, O H Sanchez, M Di Grappa, J L English, R P Hill and R Khokha
Oncogene 25: 6489-6496; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209663
EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins
G C Davies, P E Ryan, L Rahman, M Zajac-Kaye and S Lipkowitz
Oncogene 25: 6497-6509; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209662
Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translation
F Brenet, N Dussault, C Delfino, F Boudouresque, O Chinot, P-M Martin and L H Ouafik
Oncogene 25: 6510-6519; advance online publication, May 22, 2006; doi:10.1038/sj.onc.1209672
Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis
H Chen, M Li, R A Campbell, K Burkhardt, D Zhu, S G Li, H J Lee, C Wang, Z Zeng, M S Gordon, B Bonavida and J R Berenson
Oncogene 25: 6520-6527; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209653
Regulation of prostate cell growth and morphogenesis by Dickkopf-3
Y Kawano, M Kitaoka, Y Hamada, M M Walker, J Waxman and R M Kypta
Oncogene 25: 6528-6537; advance online publication, June 5, 2006; doi:10.1038/sj.onc.1209661
Oncogenomics
E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer
M Oeggerli, P Schraml, C Ruiz, M Bloch, H Novotny, M Mirlacher, G Sauter and R Simon
Oncogene 25: 6538-6543; advance online publication, September 4, 2006; doi:10.1038/sj.onc.1209946
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH
R Roylance, P Gorman, T Papior, Y-L Wan, M Ives, J E Watson, C Collins, N Wortham, C Langford, H Fiegler, N Carter, C Gillett, P Sasieni, S Pinder, A Hanby and I Tomlinson
Oncogene 25: 6544-6553; advance online publication, May 15, 2006; doi:10.1038/sj.onc.1209659
Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis
H Takada, I Imoto, H Tsuda, Y Nakanishi, C Sakakura, S Mitsufuji, S Hirohashi and J Inazawa
Oncogene 25: 6554-6562; advance online publication, May 22, 2006; doi:10.1038/sj.onc.1209657
